These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32328182)

  • 1. MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer.
    Zhang Z; Xu L; He L; Wang J; Shi X; Li Z; Shi S; Hou K; Teng Y; Qu X
    J Cancer; 2020; 11(13):3771-3782. PubMed ID: 32328182
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
    Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function.
    Wan N; Zheng J
    Oncol Lett; 2021 Jul; 22(1):507. PubMed ID: 33986868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1.
    Xia L; Li F; Qiu J; Feng Z; Xu Z; Chen Z; Sun J
    BMC Cancer; 2020 Oct; 20(1):949. PubMed ID: 33008330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.
    Choi KH; Shin CH; Lee WJ; Ji H; Kim HH
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
    Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
    Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
    Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
    OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.